Cargando…
Performance of presepsin and procalcitonin predicting culture-proven bacterial infection and 28-day mortality: A cross sectional study
Presepsin is a highly specific biomarker for diagnosing bacterial infections, but its clinical usefulness is not well validated. A retrospective cross-sectional study was conducted. Among the patients suspected bacterial infection or fulfilled the criteria of systemic inflammatory response syndrome...
Autores principales: | Park, Jiho, Yoon, Ji Hyun, Ki, Hyun Kyun, Ko, Jae-Hoon, Moon, Hee-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441687/ https://www.ncbi.nlm.nih.gov/pubmed/36072944 http://dx.doi.org/10.3389/fmed.2022.954114 |
Ejemplares similares
-
Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2022) -
Predictive Values of Procalcitonin and Presepsin for Acute Kidney Injury and 30-Day Hospital Mortality in Patients with COVID-19
por: Kim, Sin-Young, et al.
Publicado: (2022) -
Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis
por: Kim, Hanah, et al.
Publicado: (2017) -
Serum Procalcitonin and Presepsin Levels in Patients with Generalized Pustular Psoriasis
por: Nagai, Makoto, et al.
Publicado: (2018) -
Diagnostic Value and Prognostic Use of Presepsin Versus Procalcitonin in Sepsis
por: Venugopalan, Deepak P, et al.
Publicado: (2019)